From Precision to Personalized: Catalyzing AI ‐Enabled Innovation in Drug Development
Open Access
- 19 May 2026
- journal article
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (6) , e70617
Abstract
In 2015, President Obama announced the Precision Medicine Initiative in his nationally televised State of the Union address. The vision was bold: to enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward the development of individualized care. Now, more than 10 years later, how have the treatments available to patients changed?Keywords
This publication has 6 references indexed in Scilit:
- A foundation model for continuous glucose monitoring dataNature, 2026
- Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapyEP Europace, 2023
- Quantifying the Expanding Landscape of Clinical Actionability for Patients with CancerCancer Discovery, 2023
- Companion Diagnostics: State of the Art and New RegulationsBiomarker Insights, 2021
- FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation–Positive Non–Small Cell Lung CancerClinical Cancer Research, 2016
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001